As the oldest person elected president of the United States, Donald Trump has long faced questions about his health. But is it appropriate for doctors to comment publicly on a president’s mental health? In an opinion article published by The BMJ today, David Nicholl and Trisha Greenhalgh examine the ethical ...

Extreme A&E waits causing patient harm, say experts, with some saying they’d rather die at home Exclusive data published by The BMJ today show that 13,386 patients in England waited at least three days for A&E treatment last year, part of almost 500,000 who spent over 24 hours stuck in ...

Findings lend support to the lasting impact of improving early life conditions A large Swedish study published in The BMJ today suggests that an improved early home environment can have lasting positive effects across generations.  Children of parents with psychiatric or behavioural issues who were adopted before age 10 into ...

Investigation explores how an $80,000 a year drug was approved for primary progressive form of MS despite concerns over its safety and effectiveness  The US Food and Drug Administration (FDA) is reviewing a petition to revoke the approval of Roche’s top-selling drug ocrelizumab (Ocrevus) for treating primary progressive multiple sclerosis ...

Findings highlight the most effective components across different populations and contexts Extending vaccination opportunities, involving community members alongside healthcare professionals in communicating about vaccines, and providing financial incentives are among the most effective ways to increase vaccine uptake, finds an analysis of international trial evidence published by The BMJ today. ...

Buprenorphine showed a similar to slightly lower risk of developmental disorders in children compared with methadone, researchers say Children born to mothers who used buprenorphine for opioid addiction during pregnancy do not have a greater risk of neurodevelopmental disorders, such as ADHD and autism, compared with children whose mothers took ...

Two new vaccines to prevent tuberculosis (TB) are safe for use in adults and children, but they do not offer protection against all forms of TB, finds a large trial from India published by The BMJ today. TB remains a major global public health concern. In 2023, an estimated 10.8 million people ...